Macrophages express IL-15/IL15Rα complexes on their surface upon activation and are able to activate T cells in an antigen-independent way. Membrane bound IL-15 is not only 5-times more effective in inducing T cell proliferation than soluble IL-15, it also signals through different effectors and can therefore exert distinct biological responses. Membrane bound IL-15 expressed on macrophages can participate in reverse signaling between the IL-15Rα on T cells, whereas
soluble IL-15 modulates cellular function in both a paracrine and autocrine fashion [17] and [26]. Macrophages which lack IL-15/IL15Rα complex on the surface are not able to sustain a full immune response within the plaque and thereby are less capable to recruit inflammatory cells into the plaque, which is reflected in the reduced CD/CD8 ratio, indicative Lapatinib mw of a lower inflammatory status, after IL-15
vaccination. We suggest that the development of the lesion is arrested in the fatty streak stadium. This may provide an explanation for the increased number of macrophages in the vessel wall and the smaller lesion size, since mainly the innate immune response is activated and adaptive immune response is likely impaired. However, IL-15 expressing cells are activated inflammatory cells, which are also able to OSI-906 cost express other inflammatory mediators. Therefore it should be taken into account that the effect we observe may also be due to the absence of other mediators. The vaccination method used in this study may lead to the initiation of new therapies, which block the action of IL-15. There are some promising results with phase I/II clinical trails with an anti-IL-15 antibody treatment in patients with rheumatoid arthritis [27], which might be extended to cardiovascular patients. Furthermore Gokkusu et al. [28], recently demonstrated that genetic variation in IL-15 gene and
IL-15 levels influence the risk of coronary heart disease, indicating the importance of IL-15 signaling in atherosclerosis. The vaccination strategy used in this study successfully evoked a chemotoxic response targeting IL-15 expressing cells. This resulted in a vast reduction in atherosclerosis, thereby providing new insights (-)-p-Bromotetramisole Oxalate in the process of atherosclerosis and the contribution of IL-15 in this process. These new insights may contribute to the future immunomodulating treatment of patients with cardiovascular diseases. Johan Kuiper is an established investigator from the Netherlands Heart Foundation (grant 2000T040) and Gijs H.M. van Puijvelde is a postdoctoral fellow of the Netherlands Heart Foundation (2007T039). “
“Vaccines should be capable of eliciting a strong and protective immune response, but are also required to be safe. Subunit antigens are regarded safer than live-attenuated and inactivated pathogens, but lack strong immunogenicity.